Search results
Showing 7366 to 7380 of 7707 results
Doxylamine/pyridoxine (Xonvea) for treating nausea and vomiting of pregnancy (ES20)
This evidence summary has been updated and replaced by NICE guideline NG201.
In development [GID-TA11163] Expected publication date: TBC
In development [GID-TA11433] Expected publication date: TBC
Durvalumab for untreated unresectable hepatocellular carcinoma [ID4068]
Discontinued [GID-TA11041]
Atezolizumab for adjuvant treatment of renal cell carcinoma with a high risk of metastasis [ID5101]
Discontinued [GID-TA11000]
This medtech innovation briefing has been replaced by NICE diagnostic guidance on heart failure algorithms for remote monitoring in people with cardiac implantable electronic devices.
Ventripoint Medical System Plus for measuring heart volume and function (MIB310)
February 2023: The medtech innovation briefing on Ventripoint Medical System Plus for measuring heart volume and function has been withdrawn as the company have withdrawn from the process.
Pembrolizumab with lenvatinib for previously treated metastatic colorectal cancer [ID5112]
Discontinued [GID-TA11020]
Filgotinib for treating moderately to severely active Crohn's disease [ID6236]
Discontinued [GID-TA11244]
Maribavir for cytomegalovirus infection after haematopoietic stem cell transplant [ID5075]
Discontinued [GID-TA10958]
Discontinued [GID-TA10525]
Discontinued [GID-TA10185]